Transcatheter treatment of atrial fibrillation (AF) is a complex intervention performed in patients who are at inherently increased risk of a thromboembolic complication, including stroke. It is therefore not surprising that cerebrovascular accidents have been among the most feared complications since the inception of AF ablation. While improvements have been made to limit the incidence of thromboembolic events during catheter ablation of AF, the optimal strategy to minimize such complications has yet to be determined. It is hoped that larger trials using periprocedural anticoagulation strategies can be undertaken to definitively address these important concerns.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ccep.2013.10.003 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!